Hypersphyxia-causing methods

Details Hypersphyxia-causing methods Hypersphyxia-causing methods

1991-03-22

1992-12-08

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514530, A61K 3135, A61K 31215

Patent

active

051698633

ABSTRACT:
This invention provides a hypersphyxia-causing composition containing 15-keto-PGEs esters separated from any substantial activity such as decrease of blood pressure.
The present invention provides a hypersphyxia-causing composition effective to recovery of blood pressure, and heart rate in e.g. hemmorrhage shock, or hyperventilation, which comprises 15-keto PGEs esters.

REFERENCES:
patent: 4447428 (1984-05-01), Collington et al.
Chemical Abstracts, vol. 74, No. 23, Jun. 7, 1971, p. 78, Ref. No. 120819y.
Chemical Abstracts, vol. 76, No. 21, May 22, 1972, p. 75, Ref. No. 122009z.
Prostanglandins, vol. 4, No. 6, Dec. 1973, pp. 877-890, Mathe, et al.

Affiliated with

Also associated with

Rating

Hypersphyxia-causing methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hypersphyxia-causing methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypersphyxia-causing methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-961271